235 related articles for article (PubMed ID: 18061659)
21. [Role of lipid peroxidation in non-alcoholic steatohepatitis].
Fraenkel E; Lazúrová I; Fehér J
Orv Hetil; 2004 Mar; 145(12):611-8. PubMed ID: 15119115
[TBL] [Abstract][Full Text] [Related]
22. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
Tessari P; Coracina A; Cosma A; Tiengo A
Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.
Aubert J; Begriche K; Knockaert L; Robin MA; Fromenty B
Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):630-7. PubMed ID: 21664213
[TBL] [Abstract][Full Text] [Related]
24. Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol?
Ginsberg HN
Cell Metab; 2006 Sep; 4(3):179-81. PubMed ID: 16950134
[TBL] [Abstract][Full Text] [Related]
25. Hepatic microcirculation in fatty liver disease.
Farrell GC; Teoh NC; McCuskey RS
Anat Rec (Hoboken); 2008 Jun; 291(6):684-92. PubMed ID: 18484615
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis and therapy in NASH].
Tokushige K
Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
[TBL] [Abstract][Full Text] [Related]
27. Curcumin ameliorates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis.
Kuo JJ; Chang HH; Tsai TH; Lee TY
Int J Mol Med; 2012 Sep; 30(3):643-9. PubMed ID: 22692588
[TBL] [Abstract][Full Text] [Related]
28. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.
Cusi K
Clin Liver Dis; 2009 Nov; 13(4):545-63. PubMed ID: 19818304
[TBL] [Abstract][Full Text] [Related]
29. The ins and outs of mitochondrial dysfunction in NASH.
Fromenty B; Robin MA; Igoudjil A; Mansouri A; Pessayre D
Diabetes Metab; 2004 Apr; 30(2):121-38. PubMed ID: 15223984
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis.
Beraza N; Malato Y; Vander Borght S; Liedtke C; Wasmuth HE; Dreano M; de Vos R; Roskams T; Trautwein C
Gut; 2008 May; 57(5):655-63. PubMed ID: 18408102
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence?
García-Ruiz C; Baulies A; Mari M; García-Rovés PM; Fernandez-Checa JC
Free Radic Res; 2013 Nov; 47(11):854-68. PubMed ID: 23915028
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet.
Romestaing C; Piquet MA; Letexier D; Rey B; Mourier A; Servais S; Belouze M; Rouleau V; Dautresme M; Ollivier I; Favier R; Rigoulet M; Duchamp C; Sibille B
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E110-9. PubMed ID: 17986629
[TBL] [Abstract][Full Text] [Related]
33. From fatty liver to fibrosis: a tale of "second hit".
Basaranoglu M; Basaranoglu G; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1158-65. PubMed ID: 23483818
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.
Begriche K; Igoudjil A; Pessayre D; Fromenty B
Mitochondrion; 2006 Feb; 6(1):1-28. PubMed ID: 16406828
[TBL] [Abstract][Full Text] [Related]
35. Fatty liver and insulin resistance in obese Zucker rats: no role for mitochondrial dysfunction.
Flamment M; Arvier M; Gallois Y; Simard G; Malthièry Y; Ritz P; Ducluzeau PH
Biochimie; 2008 Sep; 90(9):1407-13. PubMed ID: 18534199
[TBL] [Abstract][Full Text] [Related]
36. Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model.
Zapelini PH; Rezin GT; Cardoso MR; Ritter C; Klamt F; Moreira JC; Streck EL; Dal-Pizzol F
Mitochondrion; 2008 Jun; 8(3):211-8. PubMed ID: 18417427
[TBL] [Abstract][Full Text] [Related]
37. Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3,3'-diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani.
Roy A; Ganguly A; BoseDasgupta S; Das BB; Pal C; Jaisankar P; Majumder HK
Mol Pharmacol; 2008 Nov; 74(5):1292-307. PubMed ID: 18703668
[TBL] [Abstract][Full Text] [Related]
38. Animal models of NASH: getting both pathology and metabolic context right.
Larter CZ; Yeh MM
J Gastroenterol Hepatol; 2008 Nov; 23(11):1635-48. PubMed ID: 18752564
[TBL] [Abstract][Full Text] [Related]
39. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.
Marra F; Gastaldelli A; Svegliati Baroni G; Tell G; Tiribelli C
Trends Mol Med; 2008 Feb; 14(2):72-81. PubMed ID: 18218340
[TBL] [Abstract][Full Text] [Related]
40. Involvement of free radicals and oxidative stress in NAFLD/NASH.
Sumida Y; Niki E; Naito Y; Yoshikawa T
Free Radic Res; 2013 Nov; 47(11):869-80. PubMed ID: 24004441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
